Annual report pursuant to Section 13 and 15(d)

Commitments, Significant Contracts and Contingencies (Details)

v3.19.3
Commitments, Significant Contracts and Contingencies (Details)
12 Months Ended
Aug. 31, 2019
CAD ($)
C.A.B Financial Services  
Commitments Significant Contracts And Contingencies [Line Items]  
Monthly Commitment $ 29,167 [1]
Expiry Date January 1, 2022
Docherty Management Ltd.  
Commitments Significant Contracts And Contingencies [Line Items]  
Monthly Commitment $ 25,000 [1]
Expiry Date January 1, 2022
M&E Services Ltd.  
Commitments Significant Contracts And Contingencies [Line Items]  
Monthly Commitment $ 12,960 [2],[3]
Expiry Date June 1, 2021
Corporate Development  
Commitments Significant Contracts And Contingencies [Line Items]  
Monthly Commitment $ 1,000 [4],[5]
Expiry Date Month to Month
Corporate Development  
Commitments Significant Contracts And Contingencies [Line Items]  
Monthly Commitment $ 8,000 [4],[5]
Expiry Date Month to Month
Investor relations and communications - Alex Blanchard Capital  
Commitments Significant Contracts And Contingencies [Line Items]  
Monthly Commitment $ 7,500 [2]
Expiry Date Month to Month
Office Management  
Commitments Significant Contracts And Contingencies [Line Items]  
Monthly Commitment $ 10,000 [6]
Expiry Date August 15, 2022
Research & Development  
Commitments Significant Contracts And Contingencies [Line Items]  
Monthly Commitment $ 3,854
Expiry Date Month to Month
Office Rent  
Commitments Significant Contracts And Contingencies [Line Items]  
Monthly Commitment $ 4,823 [7]
Expiry Date November 15, 2023
[1] A performance bonus equal to 50% of the annual compensation may be payable upon the completion of certain performance criteria as determined by the board of directors of Lexaria. Compensation equal to 2% of the consideration received by the Company from the sale of a subsidiary, excluding certain circumstances. Certain compensation to be paid upon a change of control excluding certain circumstances and participation in the Company's approved stock option plans.
[2] 100,000 common shares issuable upon the Company achieving non-refundable revenues of $200,000 to any single customer in any consecutive 60-day period for the first 12 months of the contract, plus a further 50,000 common shares issuable upon achieving non-refundable revenues of $200,000 to any single customer in any consecutive 60-day period, during the 13th - 24th months of the contract. If the Company achieves non-refundable revenues of $500,000 in any fiscal quarter, a further 200,000 common shares may be issuable during the first 12 months of the contract and 100,000 common shares during the 13th - 24th months of the contract.
[3] During the term of the agreement, for each provisional patent application substantively devised and successfully created, written, and filed with the U.S. Patent Office for the Company's Technology, 250,000 restricted common shares of the Company will be issuable.
[4] For new customers sourced by a Consultant for the first 12 months of the contract; for combined Lexaria Energy and ViPova products and including all combined sales efforts and/or technology licensing revenues, achieving non-refundable revenues of $200,000 to any single customer in any consecutive 60-day period would result in a restricted common share award of 100,000 Company shares (not achieved); and, during the 13th - 24th months of the contract; a restricted common share award of 50,000 Company shares may be achieved; this clause is limited to one payment per customer during the 12-month period, but payable on each customer that meets these sales/licensing thresholds.
[5] For new customers sourced by a Consultant for the first 12 months of the contract; for combined Lexaria Energy and ViPova products and including all combined sales efforts and/or technology licensing revenues, achieving non-refundable revenues of $500,000 in any fiscal quarter would result in a restricted common share award of 200,000 Company shares (not achieved); and, during the 13th - 24th months of the contract; for combined Lexaria Energy and ViPova products and including all sales efforts, achieving non-refundable revenues of $500,000 in any fiscal quarter would result in a restricted common share award of 100,000 Company shares; this clause is limited to one payment per fiscal quarter.
[6] Compensation equal to 0.4% of the consideration received by the Company from the sale of a subsidiary, excluding certain circumstances. Certain compensation to be paid upon a change of control excluding certain circumstances and participation in the Company's approved stock option plans.
[7] Corporate office and R&D lab space leased in Kelowna, British Columbia, Canada until November 15, 2023 with an option to extend an additional five years. Base rent is CDN$12.56 per square foot until November 14, 2019, CDN$12.86 per square foot until November 14, 2021 and CDN$13.21 per square foot until November 14, 2023 plus common area maintenance and taxes.